Priyanka Gogna
Kingston, ON K7L3N6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases.
Journal: Journal of comparative effectiveness research
Published: April 22, 2025
Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal: Leukemia & lymphoma
Published: October 01, 2024
A cohort study of the multipollutant effects of PM2.5, NO2, and O3 on C-reactive protein levels during pregnancy.
Journal: Environmental epidemiology (Philadelphia, Pa.)
Published: August 04, 2023
Health effects of green prescription: A systematic review of randomized controlled trials.
Journal: Environmental research
Published: May 02, 2023
External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 21, 2023
Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada.
Journal: Current oncology (Toronto, Ont.)
Published: February 22, 2023
Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data.
Journal: Leukemia & lymphoma
Published: November 21, 2022
Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50.
Journal: Preventive medicine reports
Published: October 18, 2022
Understanding real-world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population-based cohort study.
Journal: EJHaem
Published: August 17, 2022
Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers.
Journal: Current oncology (Toronto, Ont.)
Published: August 04, 2022
Last Updated: 09/26/2026